StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.10−0.05 (-2.33%)

Close on Nov 17, 2026Market cap $115.02MP/E –Yield –

Upstream Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Upstream Bio's price to book ratio was 0.6× on Nov 11, 2026, against 4.1× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×−3.2
2025Dec 31, 20253.9×–

More Upstream Bio figures

See a number that looks wrong?